Dupixent (dupilumab)

pCPA File Number: 22496
Negotiation Status:
Active Negotiation
Indication(s):
Atopic dermatitis, pediatrics
Sponsor/Manufacturer:
Sanofi Genzyme Canada
CDA-AMC Project Number:
SR0774-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable